I-Mab Biopharma
IMAB
#9469
Rank
NZ$99.02 M
Marketcap
$1.21
Share price
-6.87%
Change (1 day)
-60.07%
Change (1 year)

I-Mab Biopharma (IMAB) - Cash on Hand

Cash on Hand as of September 2024 : NZ$0.32 Billion

According to I-Mab Biopharma's latest financial reports the company has NZ$0.32 Billion in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

I-Mab Biopharma - Cash on Hand chart (from 2024 to 2023)

Cash on Hand by year

Year Cash on Hand Change
2023-12-31NZ$72.1 M-36.85%
2022-12-31NZ$0.11 B-25.93%
2021-12-31NZ$0.15 B-1.06%
2020-12-31NZ$0.15 B338.55%
2019-12-31NZ$35.52 M-38.87%
2018-12-31NZ$58.11 M205.33%
2017-12-31NZ$19.03 M

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
NZ$29.28 M-91.11%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$0.77 B 134.25%๐Ÿ‡บ๐Ÿ‡ธ USA